If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
211.50    0.00 (0.00%)
Bid:
210.00
Ask:
213.00
Spread: 3.00 (1.429%)
Market Cap: £144.31m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Revision to Adjusted Net Asset Value

16 Feb 2021 13:37

RNS Number : 2820P
Helios Underwriting Plc
16 February 2021
 

 

Helios Underwriting plc

("Helios", "Company" or the "Group")

 

Revision to Adjusted Net Asset Value

 

Helios, the unique investment vehicle which acquires and consolidates underwriting capacity at Lloyd's, announces an update on the Company's approach to determining the adjusted net asset value of the Company.

 

Adjusted net asset value

Helios has disclosed an adjusted net asset value to allow investors to assess the value of the underlying assets in the business. Two adjustments have been made to the net asset value as disclosed in the Company's historic consolidated balance sheets to arrive at an adjusted net asset value. The net asset value as disclosed in the Company's audited financial statements remains unaffected.

 

a) In the consolidated balance sheets, the value of the capacity was included at "Fair Value", being that value at the time it was acquired with an LLV, as adjusted for any impairment. A management adjustment was made to include in the adjusted net asset value the current value of the capacity as determined by reference to the weighted average prices from the last Lloyd's capacity auctions. This increased the value of capacity as at 30th June 2020 from £21.6m to £26.8m. This correctly reflected the value of the capacity portfolio.

b) A second management adjustment was made to include Group letters of credit relating to reinsurance policies of LLVs that has been acquired in the past. As at 30th June 2020, the value of these Group letters of credit was £2.9m. These reinsurance policies provide third party funds at Lloyd's ("FAL") for certain LLVs which, as off-balance sheet items, are not included on the balance sheets of LLVs. On acquisition of these LLVs, an assessment of the Fair Value of the assets acquired was made, including the assets provided by these reinsurance policies and a reserve at consolidation level was made to reflect the value of the third party FAL provided. Following an internal review, the further management adjustment to reflect the value of these assets was unnecessary as the provision on consolidation properly reflected the value of the Group letters of credit and consequently the adjusted net asset value per share was overstated.

 

The Board will be considering adopting an accounting policy to value assets at current fair value rather than using cost at the time of acquisition for both the capacity value and for the value of the Group letters of credit.

 

The table below shows the change to the calculation of the adjusted net asset value per share reflecting the capital raise as completed in November 2020, excluding the adjustment for the Group letters of credit.

 

 

As at

Jun 2020

Equity Raise (Nov 2020)

Pro forma Nov 2020

 

£'000's

£'000's

£'000's

Net tangible assets

6,397

13,268

19,665

Value of capacity (WAV)

 26,827

 

 30,826

Adjusted Net assets

33,224

 

50,491

 

 

 

 

Fully diluted share in issue, thousands

17,978

15,534

33,512

Revised ANAV per share, £

1.85

 

1.51

Latest published ANAV* fully diluted, £

2.01

 

1.55

Reduction

8.1%

 

3.0%

 

*As announced on 2 November 2020 and adjusted for the Company's Joint Share Ownership Plan shares nearing vesting, but before the effect of the weighted average price from the Lloyd's capacity auctions which was made available at the end of November 2020 and any subsequent acquisition of capacity.

 

Notes to the adjustments:

a) The capital raise in November 2020, approximately 15.288 million new ordinary shares were issued increasing shareholders' funds (net of costs) by approximately £18.0m. The increase in net tangible assets (excluding the value of capacity acquired with LLVs that were satisfied by the issue of new ordinary shares) was approximately £13.268m.

b) The value of the capacity portfolio as at 31st December 2020 reflecting the weighted average prices as at 4th quarter 2020 and the enlarged capacity portfolio has been included.

 

 

For further information please contact:

 

Helios Underwriting plc

Nigel Hanbury - Chief Executive +44 (0)7787 530 404 / nigel.hanbury@huwplc.com

Arthur Manners - Chief Financial Officer +44 (0)7754 965 917

 

Shore Capital (Nomad and Broker)

Robert Finlay +44 (0)20 7408 4080

David Coaten

Henry Willcocks

 

Willis Re Securities (Financial Adviser)

Alastair Rodger +44 (0)20 3124 6033

Quentin Perrot +44 (0)20 3124 6499

 

Buchanan

Helen Tarbet / Henry Wilson / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111 

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £110m of capacity for the 2021 account. The portfolio provides a good spread of business being concentrated in property insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVBXGDDUXBDGBL
Date   Source Headline
1st Jul 20263:27 pmRNSTotal Voting Rights
29th Jun 20267:00 amRNSTransaction in Own Shares
25th Jun 20267:00 amRNSNet Asset Value Update - Q1 2026
22nd Jun 20263:59 pmRNSResults of Annual General Meeting
22nd Jun 20269:00 amRNSTransaction in Own Shares
15th Jun 20269:00 amRNSTransaction in Own Shares
12th Jun 20267:00 amRNSScrip Dividend Reference Price
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20264:05 pmRNSGrant of LTIP Award
5th Jun 20267:00 amRNSGrant of LTIP Awards
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.